جست‌وجوی استاد و پژوهشگر

Nigel Hooperمشاهده پروفایل

استاد

• Proteases/peptidases
• Proteolytic processing/shedding
• GPI-anchored proteins
• +۵ مورد دیگر

Nigel Hooper is a Professor of Cell Biology at the Faculty of Biology, Medicine and Health, University of Manchester , where he serves as Vice Dean for Research and Innovation and Director of Dementia Research. His career spans over three decades of leadership in biochemistry and cell biology, with a focus on neurodegenerative diseases. 30+ years of experience in neurodegenerative and cardiovascular research Published 243 papers with an h-index of 55 Secured over £15 million in research funding His research explores proteases, GPI-anchored proteins, lipid rafts, and their roles in Alzheimer's disease and prion biology. His textbook Instant Notes: Biochemistry has sold 40,000+ copies worldwide. Key research areas include: Proteolytic processing in neurodegeneration Lipid raft dynamics in amyloid-beta production Zinc transport mechanisms in neuronal health Scientific awards and honors : Fellow of the Royal Society of Biology (2016) Mr & Mrs John Jaffé Royal Society Research Fellow (1987-1989) 19 plenary/invited lectures at international conferences He has supervised 40 PhD students to completion and held strategic leadership roles at University of Leeds, including Dean of Biological Sciences and Director of the Institute of Molecular and Cellular Biology.

Peer-Hendrik Kuhnمشاهده پروفایل

پژوهشگر ارشد

• Neurodegenerative Diseases
• Proteomics
• Alzheimer's Disease
• +۳ مورد دیگر

Peer-Hendrik Kuhn is a Carl von Linde Junior Fellow at the Institute for Advanced Study (TUM-IAS), Technische Universität München (TUM), since 2013. He leads the Neuroproteomics research group and collaborates with host Stefan Lichtenthaler. His work focuses on developing proteomics methods to study neurodegenerative diseases, particularly Alzheimer’s disease. Kuhn earned his MD from Ludwig-Maximilians-Universität Munich (2008–2009) and a PhD from TUM (2012), with postdoctoral training at DZNE Munich. Research Interests: Kuhn pioneered the SPECS method for secretome analysis, identifying BACE1 substrates in neurons. Current projects extend this method to hematopoietic cancers and patient specimen analysis. His lab combines metabolic labeling, mass spectrometry, and bioorthogonal chemistry to study protease substrates and cell surface proteins. Publications: Over 15 peer-reviewed articles since 2010, emphasizing BACE1/ADAM10 substrates, Alzheimer mouse models, and proteomics methodologies. Key contributions include defining ADAM10’s role in axon targeting and TDP-43’s impact on endosomal trafficking. Awards: Recipient of the Molecular Medicine MD program stipend (2003–2005) from LMU. His work has been funded through TUM-IAS fellowships and collaborative grants with institutions like DZNE. Lab & Collaborations: Neuroproteomics group at TUM-IAS focuses on method development for clinical applications. Collaborations include University of Munich medical centers, DZNE, and industry partners for biomarker identification in neurodegenerative diseases.

Stefan Lichtenthalerمشاهده پروفایل

استاد

• Alzheimer's disease
• Secretases
• Neuroinflammation
• +۵ مورد دیگر

Prof. Dr. Stefan Lichtenthaler is a full Professor at the Technical University of Munich (TUM) and Group Leader at the German Center for Neurodegenerative Diseases (DZNE) . He is also a regular member of the Graduate School of Systemic Neurosciences (GSN) and co-speaker for the Medical Life Science and Technology (TUM-MLST) PhD program . Education: Dr. rer. nat. (summa cum laude), University of Heidelberg (1998) M.Sc. thesis, University of Heidelberg (1994) Research Interests: His work focuses on the molecular basis of Alzheimer’s disease (AD), particularly proteolytic processes involving ADAM10 (alpha-secretase) , BACE1 (beta-secretase) , and gamma-secretase. He investigates their physiological roles in healthy brains, pathophysiological contributions to AD, and therapeutic targeting strategies. Additional interests include microglia-dependent inflammatory processes , genetic risk factors (e.g., RHBDF2/iRhom2, MS4A4A) , and neuroproteomics for secretome analysis and cerebrospinal fluid (CSF) diagnostics. Article Trends: Recent studies explore BACE2’s role in VEGFR3 signaling (2024), blood biomarkers for secretase activity (2022), ADAM proteases in SARS-CoV-2 infection (2022), and methodological advances in proteomics (2020). Themes emphasize protease-substrate interactions, drug development safety, and interdisciplinary approaches. Scientific Awards: Alzheimer Research Prize (Breuer Foundation, 2014) Emmy-Noether Scholarship (DFG, 1999-2001) Dr. Sophie Bernthsen Prize (1994) Advising and Collaborations: He mentors current PhD students Andree Schmidt and Laura Hoffmann, and has graduated Martina Pigoni. He contributes to academic committees, including the DZNE tenure committee and the Graduate School of Systemic Neurosciences (LMU) . Labs and Teams: His group at DZNE Munich and TUM employs Exploris 480 Orbitrap and timsTOF Pro mass spectrometers for discovery proteomics, using mouse models, iPSC-derived human cells, and clinical trial data to bridge basic research with translational applications.

Stefan Lichtenthalerمشاهده پروفایل

استاد

• Neurodegenerative Diseases
• Proteomics
• Molecular Biology
• +۳ مورد دیگر

Prof. Stefan Lichtenthaler is a Full Professor of Neuroproteomics at the Technical University of Munich (TUM) and the German Center for Neurodegenerative Diseases (DZNE). He leads the Chair of Neuroproteomics within the TUM School of Medicine and Health. His academic career includes studies at Universities of Karlsruhe, Montpellier, and Heidelberg, a PhD (summa cum laude) from Heidelberg University, and postdoctoral research at Harvard University. He became a habilitated biochemist at LMU Munich and led a junior research group there before joining DZNE as Head of Department in 2009. Since 2012, he has held his current professorship at TUM. Research Focus: Prof. Lichtenthaler’s work centers on the molecular mechanisms of neurodegenerative diseases, particularly Alzheimer’s. He employs biochemical and proteomic methods, including quantitative mass spectrometry, to study proteases like ADAM10 and BACE1, their roles in disease pathology, and the development of diagnostic/therapeutic strategies. His lab also innovates proteomic techniques for analyzing cerebrospinal fluid and secretomes. Awards: Alzheimer Research Award (2014), Emmy-Noether Fellowship (1999–2001), Dr. Sophie Bernthsen Prize (1994). Leadership Roles: Editorial board member of Journal of Alzheimer’s Disease , speaker of TUM’s PhD program in Medical Life Science and Technology. Collaborations: Partnerships with DZNE, TUM’s Biomedical Neuroscience Master’s program, and international institutions like the University of Pavia (Italy). Labs/Teams: Directs a research group focused on neuroproteomics and neurodegeneration at DZNE Munich, with interdisciplinary projects combining biochemistry, cell biology, and clinical neurology.

• Antimicrobial Peptides
• Biochemistry
• Peptide-based Antibiotics
• +۶ مورد دیگر

Professor Jörg Andrä is a distinguished academic at the Hamburg University of Applied Sciences (HAW Hamburg), where he serves as Professor of Organic Chemistry and Biochemistry and Head of the Department of Biotechnology within the Faculty of Life Sciences. He also leads the Laboratory for Organic Chemistry and Biochemistry and is a member of the Department Council for Biotechnology. His research is closely connected with the Research and Transfer Center ALSTER (Applied Life Science Technologies and Environmental Research) and the research group PharmCycle. Dr. Andrä's research focuses on peptides of the innate immune system as lead structures for developing antibiotic, anti-inflammatory, and anti-tumor drugs, with particular emphasis on biodegradable peptide-based antibiotics (PharmCycle project) and bacterial and eukaryotic cell membrane models. His work spans biochemistry, molecular biology, and pharmaceutical development, with significant contributions to understanding antimicrobial peptides and their mechanisms of action against pathogens and cancer cells. His research program includes major projects such as bioSurf (biotechnological production of antimicrobial peptides for biocidal surface coatings) and PharmCycle (a comprehensive approach to reducing antibiotic contamination in aquatic environments through sustainable antibiotic development). His publications reveal a strong focus on peptide-membrane interactions, endotoxin neutralization, and the development of novel antimicrobial and anticancer agents. Peptide-based treatment of sepsis (2011) Mechanisms of endotoxin neutralization by synthetic cationic compounds (2006) Nutrition in the critically ill (2011) Structural analysis of NK-lysin-derived peptides (2024) Professor Andrä actively supervises doctoral students, with recent completions including Dominik Wilms (2012-2016) who investigated surface structures for selective activity of antimicrobial peptides against cancer cells, and Stephanie Gross (2011-2015) who evaluated antimicrobial peptides as anti-cancer agents. His research has resulted in numerous scientific publications and patents related to antimicrobial peptides, demonstrating his significant contributions to the field of biochemistry and pharmaceutical development.

Carl Blobelمشاهده پروفایل

استاد

• Cell Signaling
• Membrane Proteins
• Autoimmune Diseases
• +۱۴ مورد دیگر

Carl Blobel is a Professor of Medicine and of Biochemistry, Cellular and Molecular Biology at Weill Cornell Medicine, and a Senior Scientist and Program Director at the Hospital for Special Surgery (HSS) in New York. He holds the Virginia F. and William R. Salomon Chair in Musculoskeletal Research and leads the Arthritis and Tissue Degeneration Program at HSS. His work bridges clinical and basic science, focusing on the molecular mechanisms of autoimmune diseases and tissue degeneration. Education: MD, Justus-Liebig University, Giessen, Germany PhD in Biochemistry and Biophysics, University of California, San Francisco (UCSF) Dr. Blobel's research centers on the iRhom/ADAM17 signaling axis, a critical regulator of TNFα, IL-6R, and EGFR signaling pathways. These pathways are central to autoimmune diseases such as rheumatoid arthritis and lupus nephritis, as well as cancer and neuroinflammation. His lab employs a multidisciplinary approach combining biochemistry, cell biology, mouse models, and patient sample analysis to understand how iRhoms and ADAM17 regulate protein ectodomain shedding and influence disease progression. His recent publications highlight the role of iRhom2 in lupus nephritis, hemophilic arthropathy, and inflammatory arthritis, demonstrating its potential as a therapeutic target. The work consistently emphasizes translational relevance, leading to the co-founding of SciRhom, a biotech startup developing function-blocking antibodies against iRhom2. Scientific Awards and Honors: Elected Member, Association of American Physicians (2015) Distinguished Affiliated Professorship, Technical University of Munich (2017) Hans Fischer Senior Fellowship Award, Institute of Advanced Studies, TUM Bayer Hemophilia Special Project Award Dr. Blobel has been continuously funded by the NIH, including a MIRA award (R35 GM134907), and holds advisory and royalty relationships with biotech companies such as SciRhom GmbH, Kerafast, and Millipore. He leads an active research laboratory at HSS and has made seminal contributions to the understanding of regulated membrane proteolysis. His h-index of 70 and over 15,000 citations reflect his significant impact in the field. Laboratory and Research Programs: Dr. Blobel leads the Laboratory for Disc Repair Strategies at HSS and directs the Arthritis and Tissue Degeneration Program. His lab is part of the broader research ecosystem at HSS and Weill Cornell Medicine, contributing to both basic science discovery and clinical translation.

Kay Grobeمشاهده پروفایل

استاد

• Heparan Sulfate Biology
• Hedgehog Signaling
• Morphogen Release Mechanisms
• +۳ مورد دیگر

Prof. Dr. Kay Grobe is a tenured Full Professor in Physiological Chemistry at the University of Münster’s Medical Faculty. He leads the Grobe Lab, focusing on the (patho)biochemistry of heparan sulfate and Hedgehog signaling pathways. His work investigates morphogen release mechanisms, matrix-dependent development, and the role of glycosaminoglycans in cellular patterning. Professor at University of Münster since 2020 Heisenberg Professor (2016–2022) Independent Group Leader since 2008 Research interests include Hedgehog signaling in development and disease, heparan sulfate biosynthesis, and protein-lipid interactions. Key projects involve Drosophila models to study morphogen transport and gradient formation. Recent work highlights roles of Dispatched and heparan sulfate in Sonic Hedgehog shedding. Over 100 publications in journals like Developmental Cell , Nature Communications , and eLife . Awards include DFG grants and the Mizutani Foundation award. Active in mentoring PhD students and postdocs, including current advisees Janna Puschmann and Jannis Wittke.

Konstantin Glebovمشاهده پروفایل

استاد

• Rare Diseases
• Neurodegenerative Diseases
• Medical Policy
• +۳ مورد دیگر

Konstantin Glebov is an Honorary Professor at the Peninsula Medical School (Faculty of Health) within the University of Plymouth. His research focuses on mechanisms and potential treatments for rare diseases, alongside exploring policies that support local communities affected by rare diseases. He is affiliated with the Rare Diseases South West initiative. His research interests include neurodegenerative diseases, particularly Alzheimer’s and related conditions, with a strong emphasis on molecular mechanisms involving TREM2, γ-Secretase, and microglial biology. He also investigates the role of sphingolipids, serotonin, and exosomes in neuronal and glial functions. Konstantin’s work spans interdisciplinary approaches, combining genetic studies, biochemical analyses, and pharmacological interventions. Recent studies emphasize the interplay between genetic variants, protein processing pathways, and neuroinflammatory responses in disease progression. No scientific awards or grants are explicitly listed in the provided text. His advisory role and student supervision details are not specified here.

Hermann Altmeppenمشاهده پروفایل

پژوهشگر

• Prion Protein Biology
• Alzheimer's Disease
• Neurodegenerative Diseases
• +۳ مورد دیگر

Hermann Altmeppen is a researcher and Head of Research Group at the Institute of Neuropathology, part of the Center for Diagnostics at the Universitätsklinikum Eppendorf (UKE), Hamburg. He is affiliated with the Faculty of Medicine at the University of Hamburg. His research focuses on neurodegenerative diseases, particularly prion protein biology, Alzheimer’s disease mechanisms, and the role of extracellular vesicles in neurological disorders. His work integrates molecular biology, immunology, and translational neuroscience. Key research interests include the role of prion protein shedding, the impact of extracellular vesicles on neuroprotection, and the pathophysiology of Alzheimer’s and other proteinopathies. Altmeppen’s studies explore mechanisms such as ADAM10-mediated proteolytic processing of prion proteins and the implications for disease progression. His recent publications highlight advancements in understanding prion protein interactions with viruses, post-COVID-19 neurological effects, and innovative methods for isolating brain-derived extracellular vesicles. Altmeppen’s work contributes to both basic science and potential therapeutic strategies for neurodegenerative conditions. No academic awards or grants are explicitly mentioned in the provided texts. His lab focuses on neurodegenerative mechanisms, with a particular emphasis on prion protein dynamics and their implications for diseases like Alzheimer’s.

Hermann Clemens Altmeppenمشاهده پروفایل

پژوهشگر

• Neurodegeneration
• Cell Biology
• Infectious Diseases
• +۳ مورد دیگر

Hermann Clemens Altmeppen is a researcher at the Institute of Neuropathology within the Medical Faculty of the University Medical Center Hamburg-Eppendorf (UKE) . His work focuses on proteolytic processing in neurodegenerative diseases, particularly prion diseases and Alzheimer's. Research Focus : Neurodegeneration, Cell Biology, Infectious Diseases Key Grants : Werner Otto Foundation, American Creutzfeldt-Jakob Disease Foundation, CRC877 Project A12 His studies investigate how proteases like ADAM10 regulate prion protein shedding and its therapeutic implications. He has contributed to understanding extracellular vesicle biology in neurological disorders and developed transgenic models for amyloid pathology. Notable findings include spatial immune mapping in post-COVID-19 brains and conformational analysis of α-synuclein in synucleinopathies. His work bridges molecular mechanisms with clinical heterogeneity in neurodegenerative conditions. Scientific Awards : Werner Otto Foundation Research Grant American CJD Foundation Project Funding CRC877 Admission (Project A12) Leibniz Center Infection Scholarship Medical Faculty UKE Young Scientists Grant Werner Otto Scholarship

Berta Puig Martorellمشاهده پروفایل

پژوهشگر

• Extracellular Vesicles (EVs)
• Neurodegenerative Diseases
• Ischemic Stroke
• +۳ مورد دیگر

Berta Puig Martorell is a researcher at the Clinic and Polyclinic for Neurology at the University Medical Center Hamburg-Eppendorf (UKE). Her work focuses on extracellular vesicles (EVs) in neurological contexts, particularly their role in intercellular communication and disease mechanisms. Specializes in EV biology and neurodegenerative diseases Investigates EVs as biomarkers and therapeutic tools in stroke Utilizes molecular biology and transgenic mouse models Her research integrates protein biochemistry , neuropathology , and cell culture systems to study EVs' involvement in conditions like Alzheimer's, prion diseases, and cerebral ischemia. Recent publications analyze EV cargo in stroke recovery and prion protein dynamics. Key scientific collaborations include work with M. Glatzel and T. Magnus across neurology and molecular medicine departments. Techniques span confocal microscopy , qPCR , and immunoprecipitation to dissect EV uptake and signaling.

Stefan Pöhlmannمشاهده پروفایل

استاد

• Virology
• Infection Biology
• Emerging Viral Diseases
• +۱۲ مورد دیگر

Stefan Pöhlmann is a Professor and Head of the Infection Biology Unit at the German Primate Center (DPZ) in Göttingen, Germany, with a concurrent professorship at Georg-August-University Göttingen. His research is centered on viral pathogenesis, host cell interactions, and therapeutic development for emerging and zoonotic viruses. His major research interests include influenza viruses , coronaviruses (SARS-CoV-2, MERS-CoV) , Ebola virus , and primate herpesviruses . He investigates viral entry mechanisms, focusing on host proteases like TMPRSS2 and furin, and explores the development of antiviral strategies such as defective interfering particles and broad-spectrum inhibitors. His work bridges molecular virology, host-pathogen interactions, and translational applications. His recent publications highlight critical contributions to understanding SARS-CoV-2 entry, revealing the roles of ACE2 and TMPRSS2, and evaluating potential therapeutics. His research spans structural biology, cell culture modeling, and in vivo pathogenesis, demonstrating a multidisciplinary approach to combating emerging infectious diseases. Stefan Pöhlmann is affiliated with several graduate programs under the Göttingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (GGNB), including Emerging Infectious Diseases, Genome Science, Molecular Biology, Molecular Medicine, and Genes in Development, Disease and Evolution, indicating active involvement in training and mentoring. He leads an active research group at the DPZ, focusing on developing diagnostic tools and predictive models for viral transmissibility. His team employs advanced techniques in virology, cell biology, and glycobiology to dissect viral mechanisms and identify therapeutic targets.

• Alzheimer's Disease Research
• Neuroproteomics
• Proteolytic Processes
• +۵ مورد دیگر

Prof. Dr. Stefan Lichtenthaler is a Full Professor of Neuroproteomics at the Technical University of Munich (TUM) School of Medicine and Health and leads a research group at the German Center for Neurodegenerative Diseases (DZNE) in Munich. His interdisciplinary research focuses on understanding the molecular mechanisms of Alzheimer's disease and developing new diagnostic and therapeutic approaches. His academic journey began with chemistry studies at the Universities of Karlsruhe, Montpellier (France), and Heidelberg. His educational milestones include: 1993-1994: M.Sc. thesis at the University of Heidelberg 1994-1998: PhD thesis (summa cum laude) at the Center for Molecular Biology, Heidelberg University 1999-2002: Postdoctoral fellowship in molecular biology at Harvard Medical School, Boston, USA Prof. Lichtenthaler's research centers on proteolytic processes in the brain, particularly focusing on the molecular scissors (proteases) ADAM10 (alpha-secretase) and BACE1 (beta-secretase), as well as newly identified genetic risk factors for Alzheimer's disease. His work investigates how these proteases and modulators function in healthy brains and contribute to Alzheimer's pathogenesis, with the goal of developing targeted treatments. His team employs a wide range of modern techniques from biochemistry, molecular and cell biology, and neurobiology, utilizing both in vitro and in vivo models of Alzheimer's disease. His recent publications demonstrate a strong focus on neuroproteomics, with particular emphasis on understanding protease functions in Alzheimer's disease, developing novel proteomic methods, and identifying potential biomarkers. The research spans fundamental molecular mechanisms to translational applications, with a clear trajectory toward improving diagnostic tools and therapeutic approaches for neurodegenerative conditions. Throughout his distinguished career, Prof. Lichtenthaler has received several prestigious awards: Alzheimer Research Award of the Hans and Ilse Breuer Foundation (2014) Emmy-Noether fellowship from the German Research Foundation (1999-2001) Dr. Sophie Bernthsen Prize (1994) Invited guest professorship at the University of Pavia, Italy (2015) Prof. Lichtenthaler actively contributes to the scientific community through various leadership roles. He serves on the editorial boards of the Journal of Alzheimer's Disease, Molecular Neurodegeneration, and the FASEB Journal. He is a member of the Medical Advisory Board of the Fritz-Thyssen Foundation and participates in several academic programs including the International Max Planck Research School for Life Science and the 'Graduate School of Systemic Neurosciences' at LMU. Additionally, he serves as the speaker for the PhD program 'Medical Life Science and Technology' (TUM-MLST) at TUM and participates in the DZNE tenure committee. His laboratory at DZNE employs advanced proteomic technologies including an Exploris 480 Orbitrap and a timsTOF Pro mass spectrometer. The research team investigates protease functions in Alzheimer's disease using various experimental systems such as mice, iPSC-derived human cells, primary mouse cells, and cell lines. Their work on developing the proteomic hiSPECS method for secretome analysis represents a significant methodological advancement in the field.

Marie Kveiborgمشاهده پروفایل

دانشیار

• ADAM proteases
• pericellular proteolysis
• protein trafficking
• +۳ مورد دیگر

Marie Kveiborg is an Associate Professor and Group Leader at the Biotech Research and Innovation Centre (BRIC) at the University of Copenhagen, where she has been employed since 2017. She is affiliated with the Department of Biomedical Sciences within the Faculty of Health and Medical Sciences. Dr. Kveiborg received her Ph.D. in Molecular Biology from Aarhus University in 2000, following her Cand.Scient. degree from the same institution in 1998. Her academic journey includes postdoctoral fellowships at Yale University and at the Institute of Molecular Pathology at the University of Copenhagen before becoming an Assistant Professor in 2006 and advancing to Associate Professor in 2008. Her research focuses on ADAM proteases (A Disintegrin and Metalloproteases) and their role in cell biology and disease, particularly cancer. She investigates how these transmembrane proteins interact with other cell surface molecules, influence growth factor receptor signaling, and contribute to tumor progression through processes like cell proliferation, migration, and invasion. Her lab employs high-throughput screening approaches to identify novel ADAM substrates and interaction partners, complemented by biochemical analyses and murine disease models. Dr. Kveiborg's recent publications (2019-2024) demonstrate a consistent research trajectory focused on ADAM proteases in cancer biology, with particular emphasis on how these enzymes regulate extracellular matrix remodeling, cell adhesion, and tumor microenvironment interactions. Her work spans multiple cancer types including colorectal, breast, and rectal cancers, with applications in understanding radiation response and metastatic processes. Young Investigator Award, Faculty of Health Sciences, Copenhagen University (2005) Young Investigator Award, the American Society of Bone and Mineral Research (2002) Young Investigator Award, the European Calcified Tissues Society (1999) As an educator, she leads molecular pathology courses for undergraduate and graduate students in molecular biomedicine and medicine, and has supervised numerous bachelor's, master's, and PhD students. She serves as a Handling Editor for Scientific Reports (Nature Publishing Group) and participates in evaluation panels for organizations like the Norwegian Cancer Society. Her research is supported by grants from major Danish funding bodies including The Danish Medical Research Council, The Danish Cancer Society, The Novo Nordisk Foundation, and The Lundbeck Foundation, as well as several private foundations.

• Cancer Protease Regulation
• Serine Proteases
• Matriptase-Prostasin System
• +۲ مورد دیگر

Annika Weile Nonboe serves as Academic Research Staff and Guest Researcher within the Department of Cellular and Molecular Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her work is centered in the Morphogenesis and Differentiation Program under the Vogel Group, focusing on protease-inhibitor dynamics in cancer pathways. Her research investigates the interplay between serine proteases matriptase and prostasin with their inhibitors HAI-1 and HAI-2, aiming to develop novel cancer therapeutics. Key areas include proteolytic regulation in epithelial homeostasis, matriptase zymogen activation mechanisms, and the role of HAI proteins in congenital disorders like tufting enteropathy. Her work bridges molecular oncology, gastrointestinal pathophysiology, and protease network biology. Dr. Nonboe's publication record demonstrates consistent contributions to biochemical and cellular journals, with emphasis on cancer protease systems. Her 2013-2022 output reveals progressive deepening into HAI protein functions, particularly HAI-2's dual roles in matriptase stabilization and prostasin regulation. Recent work explores clinical connections to colorectal carcinogenesis and sodium diarrhea disorders. Collaborative networks are evident through multi-author publications with international teams across Denmark, Austria, and Japan. Her research receives significant attention with over 150 combined Scopus citations and Mendeley readership, indicating impact in molecular cancer research circles.